English | Español
Ruth de Jauregui | Jun 2, 2017

Phase III trials of Ofev show positive results for idiopathic pulmonary fibrosis patients
Carrice Quinnie | Jun 2, 2017

Celgene sees positive results in trial of oral ozanimod for relapsing multiple sclerosis
LocalLabs News Service | May 31, 2017

K2M Group upgrades surgical device for spinal procedures
Ruth de Jauregui | May 31, 2017

Boehringer Ingelheim trial shows tiotropium Respimat improves breathing for asthma patients
Ruth de Jauregui | May 30, 2017

AstraZeneca announces top-line results in EXSCEL Phase IIIb/IV trial of Bydureon in diabetes patients
Robert Hadley | May 29, 2017

Amgen says Repatha an improvement over standard statin treatment
Robert Hadley | May 29, 2017

Dermabond Prineo Skin Closure System can save money, cut infection risks, Johnson & Johnson says
Robert Hadley | May 29, 2017

Restricted diet may trigger cravings, NIH study says

Trending
+ Regulatory
C.D. Marsden | Apr 12, 2025

Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'